12:00 AM
 | 
Oct 13, 2016
 |  BC Innovations  |  Distillery Therapeutics

Therapeutics: Ring finger protein 20 (RNF20); RNF40; kinesin spindle protein (KSP; Eg5; KIF11)

Cancer

INDICATION: Breast cancer

Cell culture and mouse studies suggest inhibiting RNF20, RNF40 or KSP could help treat breast cancer. In a human breast adenocarcinoma cell line, siRNA targeting RNF20, RNF40 or KSP increased apoptosis and decreased survival compared with scrambled siRNA,...

Read the full 191 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$35 USD
More Info >